TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.395
+0.005 (0.11%)
Nov 7, 2025, 4:00 PM EST - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $219.17 million as of November 7, 2025. Its market cap has increased by 81.48% in one year.
Market Cap
219.17M
Enterprise Value
225.34M
1-Year Change
81.48%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $219.17M, a decrease of -33.33%. That is a compound annual growth rate of -8.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 218.92M | 43.30% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | 328.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 838.97B |
| Johnson & Johnson | 449.14B |
| AbbVie | 387.61B |
| UnitedHealth Group | 293.75B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.85B |
| Merck & Co. | 213.51B |